Researchers have successfully sustained the life of brain-dead human decedents using a novel system of extracorporeal liver cross-circulation employing genetically modified pig livers. The procedure, detailed in a study published today in Nature Medicine, represents a significant, though ethically complex, advancement in the field of organ transplantation and potential bridge-to-transplant technology.
The experimental procedure involved connecting the circulatory systems of brain-dead human decedents to those of genetically engineered pigs, allowing the pig livers to filter and detoxify the human blood. The pigs used in the study were specifically bred to reduce the risk of triggering an immune response in humans, a critical hurdle in xenotransplantation. The research team, led by Dr. Shaked, focused on maintaining vital organ function in the human decedents for a period sufficient to assess the viability of potential organ transplantation.
This development arrives alongside other advancements in medical technology. Recent research published in Nature details high-efficiency base editing in the retina of primates and human tissues, offering potential therapeutic avenues for genetic eye diseases. Separately, another Nature study highlights the use of artificial intelligence in detecting and assessing Parkinson’s disease through analysis of nocturnal breathing patterns, demonstrating the growing role of AI in diagnostics. A fourth study, as well in Nature, maps decidualization resistance in patients with severe preeclampsia, offering new insights into the causes of this dangerous pregnancy complication.
The study does not disclose the duration of sustained circulation achieved in the human decedents, nor does it detail the specific genetic modifications made to the pig livers beyond stating they were designed to mitigate immune rejection. Further research is planned to optimize the procedure and assess its long-term feasibility. The team has not yet commented on the criteria used for selecting human decedents for the study, or the protocols in place to address the ethical considerations inherent in utilizing human remains for experimental purposes.
The implications of this technology extend beyond organ transplantation. The ability to temporarily sustain organ function in brain-dead individuals could provide valuable time for family members to make finish-of-life decisions or for researchers to study the effects of various interventions on failing organs. However, the use of animal organs in human systems raises significant ethical concerns, including animal welfare and the potential for zoonotic disease transmission.
As of today, Springer Nature, the publisher of Nature Medicine, maintains a neutral position regarding jurisdictional claims in published maps and institutional affiliations. The research team has scheduled a follow-up presentation at the International Society for Organ Transplantation Congress next month to discuss preliminary findings and address anticipated questions regarding the study’s methodology and ethical framework.
